WEB Clinical Assessment of IntraSaccular Aneurysm Therapy
WEBCAST
1 other identifier
observational
51
4 countries
12
Brief Summary
The objective of this clinical study is to evaluate clinical utility of the WEB Aneurysm Embolization System used to embolize intracranial aneurysms
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2011
Longer than P75 for all trials
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 25, 2013
CompletedFirst Posted
Study publicly available on registry
January 29, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedMarch 15, 2023
August 1, 2022
4 years
January 25, 2013
March 13, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Durability of occlusion
Evaluated by the Corelab
6 months
Secondary Outcomes (3)
Recurrence/recanalization rate
6 months
Modified Raymond Scale
6 months
Percentage occlusion of target aneurysm
6 months
Other Outcomes (1)
Fluoroscopy time
procedure
Study Arms (1)
Index Embolization Cohort
WEB Aneurysm Embolization System
Interventions
Treatment of intracranial aneurysms
Eligibility Criteria
Subjects with: \- Diameter and width of the aneurysm is appropriate size for treatment with the WEB Aneurysm Embolization System per device Instructions for Use
You may qualify if:
- Must be at least 18 years of age
- Must sign and date an IRB/EC-approved written informed consent prior to initiation of any study procedures
You may not qualify if:
- Must not have clinical or angiographic evidence of vasospasm
- Must not have lesion with characteristics unsuitable for endovascular treatment
- Must not have neurologic or psychiatric conditions, which preclude ability to comply with all aspects of the screening, evaluation, treatment, and the post-procedure follow-up schedule
- Must not be concurrently involved in another investigational or post-market study
- Must not have received any investigational device for treatment of the target intracranial aneurysm prior to entry into this trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
Rigshospitalet
Copenhagen, 2100, Denmark
Hôpital Beaujon
Clichy, 92118, France
CHU Gui de Chauliac
Montpellier, 34295, France
CHU Reims Maison Blanche
Reims, 51092, France
CHU Purpan
Toulouse, 31059, France
CHU Bretonneau
Tours, 37000, France
Uniklinik Koeln
Cologne, 50937, Germany
Helios Klinikum
Erfurt, 99089, Germany
Klinikum der Johann Wolfgang Goethe Universität
Frankfurt, 60528, Germany
Klinikum Vest GmbH
Recklinghausen, 45657, Germany
Klinikum Stuttgart- Katharinenhospital
Stuttgart, 70174, Germany
National Institute of Neurosciences
Budapest, H-1145, Hungary
Related Publications (4)
Pierot L, Szikora I, Barreau X, Holtmannspoetter M, Spelle L, Klisch J, Herbreteau D, Costalat V, Fiehler J, Januel AC, Liebig T, Stockx L, Weber W, Berkefeld J, Moret J, Molyneux A, Byrne J. Aneurysm treatment with the Woven EndoBridge (WEB) device in the combined population of two prospective, multicenter series: 5-year follow-up. J Neurointerv Surg. 2023 Jun;15(6):552-557. doi: 10.1136/neurintsurg-2021-018414. Epub 2022 Jul 8.
PMID: 35803731DERIVEDPierot L, Szikora I, Barreau X, Holtmannspoetter M, Spelle L, Herbreteau D, Fiehler J, Costalat V, Klisch J, Januel AC, Weber W, Liebig T, Stockx L, Berkefeld J, Moret J, Molyneux A, Byrne J. Aneurysm treatment with WEB in the cumulative population of two prospective, multicenter series: 3-year follow-up. J Neurointerv Surg. 2021 Apr;13(4):363-368. doi: 10.1136/neurintsurg-2020-016151. Epub 2020 Jun 12.
PMID: 32532858DERIVEDPierot L, Moret J, Barreau X, Szikora I, Herbreteau D, Turjman F, Holtmannspotter M, Januel AC, Costalat V, Fiehler J, Klisch J, Gauvrit JY, Weber W, Desal H, Velasco S, Liebig T, Stockx L, Berkefeld J, Molyneux A, Byrne J, Spelle L. Safety and efficacy of aneurysm treatment with WEB in the cumulative population of three prospective, multicenter series. J Neurointerv Surg. 2018 Jun;10(6):553-559. doi: 10.1136/neurintsurg-2017-013448. Epub 2017 Sep 30.
PMID: 28965106DERIVEDPierot L, Spelle L, Molyneux A, Byrne J; WEBCAST and French Observatory Investigators. Clinical and Anatomical Follow-up in Patients With Aneurysms Treated With the WEB Device: 1-Year Follow-up Report in the Cumulated Population of 2 Prospective, Multicenter Series (WEBCAST and French Observatory). Neurosurgery. 2016 Jan;78(1):133-41. doi: 10.1227/NEU.0000000000001106.
PMID: 26552042DERIVED
Related Links
- Clinical and Anatomical Follow-up in Patients With Aneurysms Treated With the WEB Device: 1-Year Follow-up Report in the Cumulated Population of 2 Prospective, Multicenter Series (WEBCAST and French Observatory).
- Safety and efficacy of aneurysm treatment with WEB: results of the WEBCAST study.
- Aneurysm Treatment With Woven EndoBridge in the Cumulative Population of Three Prospective, Multicenter Series: 2-Year Follow-up
- Aneurysm treatment with WEB in the cumulative population of two prospective, multicenter series: 3-year follow-up
- Aneurysm treatment with the Woven EndoBridge (WEB) device in the combined population of two prospective, multicenter series: 5-year follow-up
- Safety and Efficacy of Aneurysm Treatment with the WEB: Results of the WEBCAST 2 Study
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurent Pierot, MD
CHU REIMS
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2013
First Posted
January 29, 2013
Study Start
December 1, 2011
Primary Completion
December 1, 2015
Study Completion
December 1, 2019
Last Updated
March 15, 2023
Record last verified: 2022-08